Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Torrelo

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Actas Dermo-Sifiliograficas|August 27, 2010
[Inherited epidermolysis bullosa: from diagnosis to reality]A Hernández-Martín, A Torrelo
The British Journal of Dermatology|February 18, 2003
Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularisA Torrelo, A Zambrano, R Happle
Journal of the European Academy of Dermatology and Venereology : JEADV|March 1, 2006
Large aberrant Mongolian spots coexisting with cutis marmorata telangiectatica congenita (phacomatosis pigmentovascularis type V or phacomatosis cesiomarmorata)A Torrelo, A Zambrano, R Happle
Journal of the American Academy of Dermatology|April 1, 1995
Interferon therapy for chronic urticariaA Torrelo, A Harto, A Ledo
Archives of Dermatology|July 1, 1992
Metaphysical urticariaA Torrelo, F Allegue, A Harto
Journal of Dermatological Science|August 11, 1998
Informativeness of polymorphic markers for prenatal diagnosis of recessive dystrophic epidermolysis bullosa in Spanish families at riskA Torrelo, E Valverde, A Zambrano
Actas Dermo-Sifiliograficas|November 8, 2015
Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and DiagnosisJ M Azaña, A Torrelo, A Matito
Actas Dermo-Sifiliograficas|November 4, 2015
Update on Mastocytosis (Part 2): Categories, Prognosis, and TreatmentJ M Azaña, A Torrelo, A Matito
Pediatric Dermatology|June 1, 1995
Caseating cutaneous granulomas in a child with common variable immunodeficiencyA Torrelo, I G Mediero, A Zambrano
Die Pharmazie|May 18, 2016
Topical hydrocortisone 17-butyrate 21-propionate in the treatment of inflammatory skin diseases: pharmacological data, clinical efficacy, safety and calculation of the therapeutic indexR Fölster-Holst, D Abeck, A Torrelo
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Actas Dermo-Sifiliograficas|August 27, 2010
[Inherited epidermolysis bullosa: from diagnosis to reality]A Hernández-Martín, A Torrelo
The British Journal of Dermatology|February 18, 2003
Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularisA Torrelo, A Zambrano, R Happle
Journal of the European Academy of Dermatology and Venereology : JEADV|March 1, 2006
Large aberrant Mongolian spots coexisting with cutis marmorata telangiectatica congenita (phacomatosis pigmentovascularis type V or phacomatosis cesiomarmorata)A Torrelo, A Zambrano, R Happle
Journal of the American Academy of Dermatology|April 1, 1995
Interferon therapy for chronic urticariaA Torrelo, A Harto, A Ledo
Archives of Dermatology|July 1, 1992
Metaphysical urticariaA Torrelo, F Allegue, A Harto
Journal of Dermatological Science|August 11, 1998
Informativeness of polymorphic markers for prenatal diagnosis of recessive dystrophic epidermolysis bullosa in Spanish families at riskA Torrelo, E Valverde, A Zambrano
Actas Dermo-Sifiliograficas|November 8, 2015
Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and DiagnosisJ M Azaña, A Torrelo, A Matito
Actas Dermo-Sifiliograficas|November 4, 2015
Update on Mastocytosis (Part 2): Categories, Prognosis, and TreatmentJ M Azaña, A Torrelo, A Matito
Pediatric Dermatology|June 1, 1995
Caseating cutaneous granulomas in a child with common variable immunodeficiencyA Torrelo, I G Mediero, A Zambrano
Die Pharmazie|May 18, 2016
Topical hydrocortisone 17-butyrate 21-propionate in the treatment of inflammatory skin diseases: pharmacological data, clinical efficacy, safety and calculation of the therapeutic indexR Fölster-Holst, D Abeck, A Torrelo
Pageof 17